These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 826832)

  • 21. Evidence that murine pre-B cells synthesise mu heavy chains but no light chains.
    Burrows P; LeJeune M; Kearney JF
    Nature; 1979 Aug; 280(5725):838-40. PubMed ID: 112480
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins.
    Morrison SL
    J Immunol; 1979 Aug; 123(2):793-800. PubMed ID: 110881
    [No Abstract]   [Full Text] [Related]  

  • 23. Class-switching from mu to gamma 3 or gamma 2b production at pre-B cell stage.
    Sugiyama H; Maeda T; Akira S; Kishimoto S
    J Immunol; 1986 Apr; 136(8):3092-7. PubMed ID: 3082980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cluster analysis of aminoacyl-tRNAs from mouse plasmacytomas correlates chromatographic profiles with myeloma protein similarity, clonal origin of tumour lines, and the neoplastic nature of the tissues.
    Mushinski JF; Koziol JA; Marini M
    J Theor Biol; 1980 Aug; 85(3):507-21. PubMed ID: 6777607
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of mu and gamma immunoglobulin heavy chains in different cells of a cloned mouse lymphoid line.
    Burrows PD; Beck GB; Wabl MR
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):564-8. PubMed ID: 6787596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of immunoglobulin mRNA in murine myeloma cell variants defective in the synthesis of the light or heavy polypeptide chains.
    Wallach M; Ishay-Michaeli R; Givol D; Laskov R
    J Immunol; 1982 Feb; 128(2):684-90. PubMed ID: 6798120
    [No Abstract]   [Full Text] [Related]  

  • 27. Myeloma class switch variant X63.2aRI-16 secretes IgG2a and IgG1 with identical VDJ sequence.
    Zaiss S; Beyreuther K
    Eur J Immunol; 1983 Jun; 13(6):508-13. PubMed ID: 6407851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of immunoglobulin heavy chain messenger RNA by immunoprecipitation from the mouse myeloma tumor, MOPC-31C.
    Ono M; Kondo T; Kawakami M; Honjo T
    J Biochem; 1977 Apr; 81(4):949-54. PubMed ID: 407224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mutual clonal origin of the lymphoplasmocytic and lymphoma cell in alpha-heavy chain disease.
    Ramot B; Levanon M; Hahn Y; Lahat N; Moroz C
    Clin Exp Immunol; 1977 Mar; 27(3):440-5. PubMed ID: 405165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse myeloma variant with a defect in light chain synthesis.
    Morrison SL; Scharff MD
    Eur J Immunol; 1979 Jun; 9(6):461-5. PubMed ID: 115696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological distinciton of heavy chain variable regions (VH subgroups) of mouse immunoglobulins. I. Common VH determinants on the heavy chains of mouse myeloma proteins having different binding sites.
    Bosma MJ; De Witt C; Hausman SJ
    J Exp Med; 1977 Oct; 146(4):104l-53. PubMed ID: 70500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of immunoglobulin chains made in ascites extract and reticulocyte lysate programmed with mRNA from four mouse myelomas.
    Schmeckpeper BJ; Cory S; Adams JM
    Biochim Biophys Acta; 1977 Jun; 476(4):303-20. PubMed ID: 406925
    [No Abstract]   [Full Text] [Related]  

  • 33. Epitope-specific regulation. III. Induction of allotype-restricted suppression for IgG antibody responses to individual epitopes on complex antigens.
    Herzenberg LA; Tokuhisa T; Herzenberg LA
    Eur J Immunol; 1982 Oct; 12(10):814-8. PubMed ID: 6184234
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Fusion of two immunoglobulin-producing myeloma cells.
    Cotton RG; Milstein C
    Nature; 1973 Jul; 244(5410):42-3. PubMed ID: 4582485
    [No Abstract]   [Full Text] [Related]  

  • 35. Deletion of hinge region of human myeloma IgG1 molecule (protein LEC) associated with nonexpression of G1m (3) and Km (1, 2) allotypes. A possible genetic explanation at the DNA level.
    Rivat C; Schiff C; Rivat L; Ropartz C; Fougereau M
    Eur J Immunol; 1976 Aug; 6(8):545-51. PubMed ID: 61877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successive switching of antibody isotypes expressed within the lines of a B-cell clone.
    Gearhart PJ; Hurwitz JL; Cebra JJ
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5424-8. PubMed ID: 6776537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of J chain biosynthesis in relation to heavy and light chain synthesis, polymerization and secretion.
    Kaji H; Parkhouse ME
    J Immunol; 1975 Apr; 114(4):1218-20. PubMed ID: 804006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thirteen hybridomas secreting hapten-specific immunoglobulin E from mice with Iga or Igb heavy chain haplotype.
    Rudolph AK; Burrows PD; Wabl MR
    Eur J Immunol; 1981 Jun; 11(6):527-9. PubMed ID: 6790293
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions.
    Rao DN; Rudikoff S; Krutzsch H; Potter M
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2890-4. PubMed ID: 111245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amino acid sequence of a human immunoglobulin G3m(g) pFc' fragment.
    Michaelsen TE; Frangione B; Franklin EC
    J Immunol; 1977 Aug; 119(2):558-63. PubMed ID: 407300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.